Akashi Therapeutics

About:

Akashi Therapeutics is a clinical stage biopharmaceutical company.

Website: http://akashirx.com

Description:

Akashi Therapeutics formerly known as Dart Therapeutics Inc. Akashi Therapeutics is a clinical stage biopharmaceutical company. Our mission is to develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases. Akashi was founded by leading patient organizations and biotechnology industry veterans and is managed by a seasoned team of drug development experts. Akashi is developing a cocktail of medications with the goal of transforming Duchenne from a 100% fatal, aggressive muscle-wasting disease to a chronic, manageable condition.

Total Funding Amount:

$1.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2012-01-01

Contact Email:

INFO(AT)DARTRX.COM

Founders:

Benjamin Seckler

Number of Employees:

1-10

Last Funding Date:

2014-07-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai